Page 1

Exhibit 99.1 HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update Proposed business combination with Fortitude , a vertically - integrated digital asset mining platform anchored in Zcash , continues to progress , with closing expected in Q4 calendar 2026 Commercial effort concentrated on the MyoVista Insights ™ platform , with first US commercial agreements signed and selection as the AI- ECG delivery platform for a major European reference center Southlake , TX , September 15 , 2026 ( GLOBE NEWSWIRE ) -- HeartSciences Inc. ( Nasdaq : HSCS ; HSCSW ) ( “ HeartSciences " or the " Company " ) , a healthcare information technology ( “ HIT ” ) company focused on advancing electrocardiography ( " ECG " or " EKG " ) through the integration of artificial intelligence ( " AI " ) , today reported financial results for its fiscal first quarter ended July 31 , 2026 ( " FQ1 2027 " ) and provided a business update . Proposed Transaction with Fortitude The proposed business combination with Fortitude Mining Holdings , Inc. ( " Fortitude " ) , announced in June 2026 ( the " Proposed Transaction " ) , continues to progress . The Company expects to close the Proposed Transaction in Q4 calendar 2026 , subject to customary closing conditions , including approval by HeartSciences ' shareholders . Fortitude is a meaningful part of the Zcash ecosystem and , in our view , Zcash has been among the best - performing large capitalization digital assets over the past year and is attracting growing institutional interest . Since announcement of the Proposed Transaction , Fortitude has reported a number of developments , including : • Execution of a purchase agreement for 9,000 Z15 Pro miners , representing approximately 7.5 Gsol / s of Zcash mining capacity ; • Energization of its 12 MW facility in Grand Island , Nebraska ; and • Acquisition of a 12.5 MW facility in Prosser , Nebraska . In August 2026 , Fortitude subscribed for approximately $ 1.0 million of shares of HeartSciences ' common stock . The exchange ratio under the merger agreement between Fortitude and the Company was not adjusted as a result , and no additional shares will be issued to Fortitude at closing in respect of the amount invested . Myo Vista Insights HeartSciences has continued to concentrate its commercial effort on MyoVista Insights , a device - agnostic ECG management and AI orchestration platform that works with the ECG hardware hospitals already own . Progress in the period and since includes : • First US commercial agreements signed following full launch ; • Availability of the first third - party FDA - cleared AI - ECG algorithm through the AI - ECG algorithm marketplace , with the platform now at version 1.4 following further upgrades since launch ; Selection of MyoVista Insights as the ECG management and AI - ECG delivery platform for a clinical program at a major European reference center , which is anticipated to extend into a larger multicenter project ; Launch of a new corporate website built around MyoVista Insights , giving the healthcare industry and its wider stakeholders a much clearer account of the platform's purpose , functionality , interoperability and benefits , and of how the AI - ECG marketplace is designed to deliver algorithms directly into clinical workflows ; and Continued expansion of the patent portfolio , including the grant of a European patent for ECG - based assessment of diastolic function , taking the portfolio to more than 45 granted patents . The Company's resources continue to be directed primarily to MyoVista Insights . Feedback from clinicians and health systems has been consistently positive , and our priorities are growing revenue , building relationships with key reference centers , and expanding the number of algorithms available through the AI - ECG marketplace .